Biogel Introduces Polyisoprene (PI) Indicator Underglove

... PI surgical gloves to form a synthetic, patented puncture indication system. The double-glove puncture indication system provides an immediate visual ... of fluid. Biogel's existing Patented puncture Indicator System, using latex gloves, alerts ...

Spinal taps carry higher risks for infants and elderly, study shows

... by the procedure can be reduced by doing the puncture at the middle of the lower back rather than at ... this procedure." Fluoroscopy-guided lumbar puncture is used most often to diagnose patients who have ... All had received a fluoroscopy-guided lumbar puncture in emergency room, outpatient or inpatient ...

Most babies with uncomplicated febrile seizures can avoid spinal tap

... where their workup frequently includes a lumbar puncture (spinal tap) to rule out bacterial meningitis. ... call on physicians to consider doing a lumbar puncture in children 12 to 18 months old with a first ... febrile seizure and to "strongly" consider lumbar puncture for infants 6 to 12 months old. But when Amir and ...

Barefoot Lifestyle Has Its Dangers

... shoes and socks suffer injuries such as cuts and puncture wounds. In some cases, those injuries develop ... may not "feel" a foot injury. If you suffer a puncture wound in your foot, see a doctor within 24 hours. A puncture wound must be cleaned properly and monitored ...

Going barefoot? Beware!

... thousands will suffer injuries such as cuts and puncture wounds. Some will develop nasty infections that ... a foot and ankle surgeon within 24 hours for a puncture wound. Why: These injuries can embed unsterile foreign objects deep inside the foot. A puncture wound must be cleaned properly and monitored ...

ExoSeal vascular plug gets good reviews in ECLIPSE study

... A new bioabsorbable plug that seals the arterial puncture site used for threading catheters into the body ... acid. It is anchored in place on top of the puncture in the femoral artery, after the catheter is ... the devices applicability in patients with access puncture sites at or below the branchpoint of the femoral ...

Cardiva Medical, Inc. to Present Highlights of the Boomerang Catalyst(TM) II System at the 'Investment in Innovation (In3) West' Conference on February 29, 2008 in Las Vegas, NV

... two primary methods to close the femoral artery puncture site: direct manual compression over the puncture site or one of the various implantable vascular ... or staples) to create a physical seal of the puncture site. "The Catalyst II device promises to build ...

Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)

... two primary methods to close the femoral artery puncture site: direct manual compression over the puncture site or one of the various implantable vascular ... staples) to create a physical seal of the puncture site. There are considerable drawbacks to ...

Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)

... two primary methods to close the femoral artery puncture site: direct manual compression over the puncture site or one of the various implantable vascular ... staples) to create a physical seal of the puncture site. There are considerable drawbacks to ...

Americans United for Life Applauds Fourth Circuit Protecting Women and Children by Upholding Virginia Partial Birth Abortion Statute

... abortions -- can have devastating health effects, including uterine puncture or rupture, puncture of the uterine artery, permanent injury to the cervix, and risks for ...

CPC Launches New Web Site Highlighting Medical, Research and Technical Panel, MedClose(TM) VCS Animated Video

... intended for use with a biological sealant to seal the femoral arterial puncture site following diagnostic or interventional catheterization procedures. ... closure system (VCS) that is intended to seal the femoral arterial puncture site following diagnostic or interventional catheterization procedures. ...

Large study identifies most costly adverse events in children's hospitals

... of hospital stay from PDI events ranged from 2.8 days for accidental puncture and laceration to 23.5 days for postoperative sepsis. Excess overall charges ranged from $34,884 for accidental puncture and laceration to $337,226 for in-hospital mortality after pediatric heart ...

National Quality Forum Endorses Consensus Standards for Quality of Hospital Care

... average length of stay-deliveries Patient Safety, Adult -- Accidental puncture or laceration -- Death in low mortality DRGs -- Iatrogenic ... age 18 years and older Patient Safety, Pediatrics -- Accidental puncture or laceration -- Decubitus ulcer -- Iatrogenic pneumothorax in ...

Researchers find relief for chronic pain

... new study Sensory neuron targeting by self-complementary AAV8 via lumbar puncture for chronic pain published in the January 22, 2008 issue of the ... as morphine. Based on our findings, this targeted gene therapy via lumbar puncture appears to be a promising candidate for bench-to-bedside research that ...

Kensey Nash Corporation Announces its Fourth Quarter and Fiscal Year End 2009 Earnings Release Date and Teleconference

... cardiology, orthopedic, sports medicine, spine, endovascular and general surgery markets. The company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc. ...

Kenneth Kensey, Inventor of the Angio-Seal(R), Dies at 58

... Corporation in 1984, where he was responsible for creating numerous new medical technologies including the Angio-Seal(R), the leading femoral artery puncture closure device marketed by St. Jude Medical, as well as the Kensey Catheter for Dynamic Angioplasty. Dr. Kensey's devices are in use worldwide. His ...

Pennsylvania Patient Safety Authority Releases June Advisory

... The Authority has received 376 reports of complications that occur during certain gynecologic procedures. The most commonly reported event is the puncture of organs (77%), most frequently the uterus (96%). This article details the information found in the data and gives risk reduction strategies for ...

Cytox Raises Pre-Series A Financing From Management and Existing UK Investors, Welcomes First US Investors

... require only a single blood draw from the patient, which is significantly less invasive than tests requiring cerebrospinal fluid obtained by lumbar puncture (spinal tap) and quicker and cheaper than repeated imaging techniques (MRI). Cytox's blood biomarkers have been validated for use in FDA trials ...

ThromCat(R) XT(TM) Thrombectomy Catheter System Receives CE Mark

... Licensing Agreement and a Development and Regulatory Services Agreement. The Company is known as a pioneer in the field of biomaterials and arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc. Cautionary ...

Kensey Nash Corporation's CEO & President, Joe Kaufmann Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Winner in Greater Philadelphia Region

... of absorbable biomaterials, which has led to partnerships to commercialize technologies. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc. About ...

Kensey Nash Corporation Adopts Stockholder Rights Plan

... of absorbable biomaterials, which has led to partnerships to commercialize technologies. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc. Cautionary ...

Abbott Announces Launch of Next-Generation Embolic Protection System

... treatment option. During a carotid stenting procedure, an embolic protection system and stent are deployed using a catheter inserted into a small puncture in an artery in the patient's groin area. The patient usually remains conscious while the stent is implanted at the site of the blockage. The stent ...

Kensey Nash to Present at the Jefferies 3rd Annual Healthcare Conference

... of absorbable biomaterials, which has led to partnerships to commercialize technologies. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc. ...

CPC Files Patent for Synthetic Sealant for the MedClose(TM) Vascular Closure System (VCS)

... initially with 6-9Fr applications. The MedClose(TM) VCS device consists of two parts; (1) A delivery system that delivers the sealant to the puncture site, and, (2) the synthetic sealant itself. While we will continue to refine the MedClose(TM) VCS device commercially, we have already reached the ...

Kensey Nash to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference

... of absorbable biomaterials, which has led to partnerships to commercialize technologies. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc. ...

Product Stewardship Institute Announces Two New Sustaining Partners

... and easy-to-use solution to dispose of medical waste such as hypodermic needles, lancets and any other medical device or objects used to puncture or lacerate the skin (referred to as "sharps"). The Company also offers a number of products specifically designed for the home healthcare market and ...

Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results

... to manufacture and develop these products for Spectranetics for a period of time. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc. Cautionary ...

Kensey Nash Corporation Announces Its Third Quarter 2009 Earnings Release Date and Teleconference

... of absorbable biomaterials, which has led to partnerships to commercialize technologies. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc. ...

Study: Every 1.7 minutes a Medicare beneficiary experiences a patient safety event

... failure Post-operative pulmonary embolism or deep vein thrombosis Post-operative sepsis Post-operative abdominal wound dehiscence Accidental puncture or laceration Transfusion reaction ...

New Device Treats Common Heart Rhythm Disorder

... a leg vein to guide the device into the heart; the device travels through the heart's right chamber and is deposited into the left atrium through a puncture hole between the two chambers of the heart, the researchers explained. Current treatment with warfarin is effective in preventing strokes caused ...

Kensey Nash Announces 600,000 Share Stock Repurchase Program

... of absorbable biomaterials, which has led to partnerships to commercialize technologies. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc. Cautionary ...

Glass tables: An overlooked safety threat

... MD, of the Division of Emergency Medicine at Children's Hospital Boston, who led the study. Last December, a Rhode Island girl died from a severe puncture wound to her leg. After earlier media reports about children seen at Children's Hospital Boston with severe lacerations, Consumers Union collaborated ...

Penn Medicine pathologists pioneer biomarker test to diagnose or rule out Alzheimer's disease

... the Penn Alzheimer's Disease Core Center and at ADNI trial sites around the US and Canada, we have validated a test where a safe, simple lumbar puncture can provide information to confirm suspected Alzheimer's disease and predict the onset of the disease," said John Q. Trojanowski, MD, PhD, Director ...

Kensey Nash to Participate in the Sidoti Thirteenth Annual New York Emerging Growth Institutional Investor Forum Conference

... of absorbable biomaterials, which has led to partnerships to commercialize technologies. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc. ...

CPC Pursues Development of Proprietary Synthetic Sealants as part of MedClose(TM) Global Commercialization

... commercialization strategy for MedClose(TM). MedClose(TM) is an investigational-stage vascular closure system that is intended to seal arterial puncture sites following diagnostic or interventional catheterization procedures. CPC will develop synthetic PEG sealants as platform technologies for ...

Kensey Nash Announces Appointment of Chief Financial Officer

... of absorbable biomaterials, which has led to partnerships to commercialize technologies. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc. ...

Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results

... and easy-to-use solution to dispose of medical waste such as hypodermic needles, lancets and any other medical device or objects used to puncture or lacerate the skin (referred to as "sharps"). The Sharps(R)MWMS(TM), a Medical Waste Management System, is a comprehensive medical waste ...

Kensey Nash Announces Director Resignation

... of absorbable biomaterials, which has led to partnerships to commercialize technologies. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc. ...

Sharps Compliance Announces $40 Million U. S. Government Contract

... and easy-to-use solution to dispose of medical waste such as hypodermic needles, lancets and any other medical device or objects used to puncture or lacerate the skin (referred to as "sharps"). The Company also offers a number of products specifically designed for the home healthcare market ...

Most support Alzheimer's research based on family consent

... Institute on Aging. The participants answered questions regarding one of four randomly assigned surrogate-based research scenarios: lumbar puncture study, a drug randomized control study, a vaccine study and a gene transfer study. Each participant answered three questions: whether our society ...